Former Helios TGen Scholar Exploring New Treatments for Cancer
Author: Helios Education FoundationMarch 10, 2016
Each year, 45 future scientists participate in one of the nation’s most advanced summer internship programs at the Translational Genomics Research Institute (TGen). Each intern spends eight weeks participating in biomedical investigations with one-on-one guidance and mentorship of TGen researchers. This experience provides them with a hands-on understanding of biomedical discovery.
The Helios Scholars at TGen program allows high school, undergraduate and graduate level students to conduct independent scientific research affecting real-world patients. Like their mentors, Helios Scholars use cutting-edge technology to help discover the genetic causes of diseases such as diabetes, Alzheimer's disease, infectious diseases and many types of cancer.
This year, Helios and TGen are celebrating the 10th anniversary of this innovative program and celebrating the accomplishments of the nearly 400 students who have participated. Past scholars have gone on to accomplish an array of impressive activities including: publishing scientific abstracts and scientific papers, earning top national student rankings, gaining acceptance into first-rate graduate and medical schools, and even earning Goldwater and Fulbright scholarships.
One such scholar, Sophie Wix, is among the next generation of biomedical researchers studying tumor cells and exploring new treatments for cancer at the University of Southern California. Click below to view a short video from USC about Sophie and the groundbreaking research she is conducting.